SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-565802
Filing Date
2016-04-29
Accepted
2016-04-29 06:09:08
Documents
5
Period of Report
2016-06-13
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d133015ddef14a.htm DEF 14A 461643
2 GRAPHIC g133015g13y62.jpg GRAPHIC 26486
3 GRAPHIC g133015g60r81.jpg GRAPHIC 31873
4 GRAPHIC g133015page2.jpg GRAPHIC 51382
5 GRAPHIC g133015page3.jpg GRAPHIC 57449
  Complete submission text file 0001193125-16-565802.txt   693509
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35703 | Film No.: 161602357
SIC: 2834 Pharmaceutical Preparations